Michael Johnsen, senior editor, has been covering the business of over-the-counter medicines and natural health issues for more than 10 years. Johnsen worked as a retail store manager for the decade prior to becoming a journalist and earned his bachelor’s degree in communication from George Mason University.
Articles by this author:
- Walgreens expects to close Alliance Boots transaction on Dec. 31 (Exclusive News Alert, Retail News, Walgreens, DSN AM, Latest News, Top Retailers)Tue, 12/23/2014 - 10:05am
Walgreens expects to close its merger with Alliance Boots by the end of the year, pending shareholder approval on Dec. 29, the retailer announced Tuesday.
Shares of Walgreens were on the rise in pre-market trading Tuesday morning, as Walgreens reported a 16.4% lift in quarterly profit to $809 million that was credited to the 222 million prescriptions filled in the first quarter ended Nov. 30.
Walgreens on Friday announced that it intends to apply to list the shares of Walgreens Boots Alliance common stock on The Nasdaq Stock Market under the ticker symbol “WBA” following the closing of the previously announced reorganization of Walgreens into a holding company structure.
M.D. Science Lab, manufacturers of Swiss Navy Premium Lubricants, on Thursday unveiled all-new packaging for their brand for mass-market storefronts.
Dollar General on Friday stated that it remains actively engaged in discussions with the Federal Trade Commission regarding the extent of potential divestitures that would be required in connection with an acquisition of Family Dollar Stores.
The overwhelming majority of GlaxoSmithKline shareholders on Thursday approved the proposed transaction with Novartis.
Teva Pharmaceutical announced that the Food and Drug Administration approved QNasl (beclomethasone dipropionate) 40 mcg for the treatment of nasal symptoms associated with allergic rhinitis in children ages 4 years to 11 years.